Mass spectrometry assay method for detection and quantitation of kidney function metabolites
AssigneeMetabolon, Inc.
InventorsLisa Ford, Tiffany A. Freed, Deirdre M. Hauser, Kelli Goodman
Life of this patent
Estimating the term…
Loading patent…
AssigneeMetabolon, Inc.
InventorsLisa Ford, Tiffany A. Freed, Deirdre M. Hauser, Kelli Goodman
Estimating the term…
A method for determining in a sample, by mass spectrometry, the amount of one or more analytes selected from the group consisting of N-acetylthreonine, TMAP, phenylacetylglutamine, tryptophan, creatinine, meso-erythritol, arabitol, myo-inositol, N-acetyl serine, N-acetylalanine, 3-methylhistidine, trans-4-hydroxyproline, kynurenine, urea, C-glycosyltryptophan, 3-indoxyl sulfate, pseudouridine, and combinations thereof is described. The method comprises subjecting the sample to an ionization source under conditions suitable to produce one or more ions detectable by mass spectrometry from each of the one or more of the analytes; measuring, by mass spectrometry, the amount of the one or more ions from each of the one or more analytes; and using the measured amount of the one or more ions to determine the amount of each of the one or more analytes in the sample. Also described is a kit comprising one or more isotopically labeled analogues as internal standards for each of the one or more analytes.
A method for detecting and determining in a sample the amount of five or more kidney function analytes, the method comprising:
Dependencies are inferred from the claim text.